SEC 13F Intelligence

Hayek Kallen Investment Management / TMO

Hayek Kallen Investment Management’s Thermo Fisher Scientific Inc Position

Does Hayek Kallen Investment Management own Thermo Fisher Scientific Inc (TMO)? Yes — 9.0K shares worth $4M (+1.44% of its 13F portfolio) as of Q1 2026, down from 9.5K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
9.0K
% of Portfolio
+1.44%
Quarters Held
27
currently held

Position History TMO

Reported value by quarter
Q1 ’19: $5MQ1 ’19Q2 ’19: $6MQ3 ’19: $5MQ4 ’19: $6MQ1 ’20: $5MQ1 ’20Q3 ’20: $7MQ4 ’20: $7MQ1 ’21: $7MQ2 ’21: $8MQ2 ’21Q3 ’21: $8MQ4 ’21: $9MQ1 ’22: $8MQ2 ’22: $7MQ2 ’22Q3 ’22: $7MQ4 ’22: $7MQ1 ’23: $6MQ2 ’23: $6MQ2 ’23Q3 ’23: $6MQ4 ’23: $6MQ1 ’24: $6MQ2 ’24: $6MQ2 ’24Q3 ’24: $7MQ4 ’24: $5MQ1 ’25: $5MQ2 ’25: $4MQ2 ’25Q3 ’25: $5MQ1 ’26: $4Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20269.0K$4M+1.44%
Q3 20259.5K$5M+1.45%
Q2 202510.0K$4M+1.38%
Q1 202510.3K$5M+1.88%
Q4 202410.5K$5M+1.99%
Q3 202410.8K$7M+2.36%
Q2 202411.0K$6M+2.26%
Q1 202411.0K$6M+2.45%
Q4 202311.1K$6M+2.46%
Q3 202311.1K$6M+2.52%
Q2 202311.3K$6M+2.51%
Q1 202311.3K$6M+2.94%
Q4 202212.3K$7M+3.13%
Q3 202212.9K$7M+3.06%
Q2 202212.9K$7M+3.06%
Q1 202213.2K$8M+2.88%
Q4 202113.6K$9M+3.22%
Q3 202114.0K$8M+3.65%
Q2 202115.0K$8M+3.19%
Q1 202115.5K$7M+3.20%
Q4 202015.7K$7M+3.54%
Q3 202015.9K$7M+3.93%
Q1 202016.5K$5M+3.15%
Q4 201917.1K$6M+3.22%
Q3 201918.3K$5M+3.34%
Q2 201919.1K$6M+3.55%
Q1 201919.5K$5M+3.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hayek Kallen Investment Management’s full portfolio or all institutional holders of TMO.